Cordovacann CORP. (LVRLF) — SEC Filings
Latest SEC filings for Cordovacann CORP.. Recent 20-F/A filing on Apr 28, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.
View Cordovacann CORP. on SEC EDGAR
Overview
Cordovacann CORP. (LVRLF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 20-F/A filed on Apr 28, 2025: CordovaCann Corp. filed a 20-F/A amendment on April 28, 2025, for the fiscal year ending June 30, 2024. The filing details financial information, including assets and liabilities, with specific figures such as $10,097,379 in total assets and $21,677,379 in total liabilities for the fiscal year 2024.
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 1 bearish, 1 neutral. The dominant filing sentiment for Cordovacann CORP. is bearish.
Filing Type Overview
Cordovacann CORP. (LVRLF) has filed 1 20-F/A, 1 20-F with the SEC between Dec 2024 to Apr 2025.
Filings by Year
Recent Filings (2)
-
CordovaCann Corp. Files 20-F/A Amendment
— 20-F/A · Apr 28, 2025 Risk: medium
CordovaCann Corp. filed a 20-F/A amendment on April 28, 2025, for the fiscal year ending June 30, 2024. The filing details financial information, including asse -
CordovaCann Corp. Files 20-F for FY2024
— 20-F · Dec 16, 2024 Risk: medium
CordovaCann Corp. filed its 20-F annual report for the fiscal year ending June 30, 2024. The company, formerly known as LiveReel Media Corp, is incorporated in
Risk Profile
Risk Assessment: Of LVRLF's 2 recent filings, 0 were flagged as high-risk, 2 as medium-risk, and 0 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Top Tags
financials (2) · amendment (1) · liabilities-exceed-assets (1) · annual-report (1) · company-information (1)
Key Numbers
- Total Assets (FY2024): $10.1M — Represents the company's total assets as of June 30, 2024.
- Total Liabilities (FY2024): $21.7M — Represents the company's total liabilities as of June 30, 2024.
- Fiscal Year End: 2024-06-30 — The end date of the reporting period for the financial statements.
- Total Assets: 10,097,379 — Represents the company's total assets as of the fiscal year end.
- Total Liabilities: 21,677,379 — Represents the company's total liabilities as of the fiscal year end.
- Current Ratio: 0.98 — Indicates the company's ability to meet short-term obligations.
- Debt-to-Equity Ratio: 0.65 — Measures the company's financial leverage.
Frequently Asked Questions
What are the latest SEC filings for Cordovacann CORP. (LVRLF)?
Cordovacann CORP. has 2 recent SEC filings from Dec 2024 to Apr 2025, including 1 20-F/A, 1 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LVRLF filings?
Across 2 filings, the sentiment breakdown is: 1 bearish, 1 neutral. The dominant sentiment is bearish.
Where can I find Cordovacann CORP. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Cordovacann CORP. (LVRLF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Cordovacann CORP.?
Financial highlights for Cordovacann CORP. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for LVRLF?
Investment thesis data for LVRLF will be available once enriched filings are processed.
Who are the key executives at Cordovacann CORP.?
Executive information for Cordovacann CORP. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Cordovacann CORP. stock?
Of LVRLF's 2 assessed filings, 0 were flagged high-risk, 2 medium-risk, and 0 low-risk.
What are recent predictions and forward guidance from Cordovacann CORP.?
Forward guidance and predictions for Cordovacann CORP. are extracted from SEC filings as they are enriched.